Decreased serum lipocalin-2 levels in human immunodeficiency virus-infected patients: increase during highly active anti-retroviral therapy
Authors:
Open Access
- 30 January 2008
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 152 (1) , 57-63
Abstract
Although neutrophil gelatinase-associated lipocalin (NGAL) may play a pivotal role in the innate immune response, there are currently no data on NGAL levels in human immunodeficiency virus (HIV)-infected patients. In this study we aimed to examine the regulation of NGAL in HIV infection. The regulation of NGAL in HIV infection was examined by different experimental approaches, including studies in peripheral blood and mononuclear cells (MNC) from bone marrow aspirates before and during highly active anti-retroviral therapy (HAART). We found that: before initiating HAART, HIV-infected patients (n = 37) had significantly decreased serum NGAL levels compared with healthy controls (n = 26); (ii) during HAART, there was a gradual and significant increase in NGAL concentrations reaching levels comparable to those in healthy controls after 12 months; (iii) this increase was seen primarily in virological responders to HAART (HIV RNA level <200 copies/ml after 24 months); (iv) phytohaemagglutinin-stimulated NGAL release in MNC cells from bone marrow aspirates was decreased in untreated HIV-infected patients compared with healthy controls, but increased after 26 weeks on HAART; and (v) there was a significant positive correlation between neutrophil counts and NGAL levels at all time-points during HAART. We have shown decreased NGAL levels in HIV-infected patients, potentially reflecting decreased number and function of neutrophils as well as impaired bone marrow myelopoiesis. These abnormalities were reversed by successful HAART. Our findings underscore further the involvement of neutrophils and innate immunity in HIV-related immunodeficiency.Keywords
This publication has 31 references indexed in Scilit:
- Neutrophil Gelatinase-associated Lipocalin, a Siderophore-binding Eukaryotic ProteinBioMetals, 2006
- Toll-like receptor 2-dependent and -independent activation of macrophages by group B streptococciImmunology Letters, 2006
- Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating ironNature, 2004
- The Neutrophil Lipocalin NGAL Is a Bacteriostatic Agent that Interferes with Siderophore-Mediated Iron AcquisitionMolecular Cell, 2002
- Reversal of Human Immunodeficiency Virus Type 1-Associated Hematosuppression by Effective Antiretroviral TherapyClinical Infectious Diseases, 2000
- Neutropenia, Neutrophil Dysfunction, and Bacterial Infection in Patients with Human Immunodeficiency Virus Disease: The Role of Granulocyte Colony-Stimulating FactorClinical Infectious Diseases, 2000
- IMMUNOPATHOGENESIS OF HIV INFECTIONAnnual Review of Microbiology, 1996
- Serum measurements of human neutrophil lipocalin (HNL) discriminate between acute bacterial and viral infectionsScandinavian Journal of Clinical and Laboratory Investigation, 1995
- Impairment of neutrophil chemotactic and bactericidal function in children infected with human immunodeficiency virus type 1 and partial reversal after in vitro exposure to granulocyte-macrophage colony-stimulating factorThe Journal of Pediatrics, 1990
- Impaired Neutrophil Function in Patients With AIDS or AIDS-Related Complex: A Comprehensive EvaluationThe Journal of Infectious Diseases, 1988